Peter Goldstein
Principal Investigator in the C.V. Starr Laboratory for Molecular Neuropharmacology in the Department of Anesthesiology · Weill Cornell Medical College
Credentials: · ·
History
Columbia-Presbyterian Hospital
Mt. Sinai Hospital
Research
Cell stem cell · 2013 · 485 citations
Emerging molecular mechanisms of general anesthetic action
Review · Trends in Pharmacological Sciences · 2005 · 433 citations
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells
Nature · 2012 · 271 citations
4 papers
4 papers · 1 as a resident
4 papers · 2 as a resident
- SK
4 papers · 2 as a resident
3 papers
3 papers · 1 as a resident
3 papers
3 papers
Grants
- 2026–2028
National Institute of Neurological Disorders and Stroke · R61
Contact PI · $635.1K · Weill Medical Coll of Cornell Univ
- 2022–2026
Live Nasal Recombinant B. pertussis Vaccine Against Tuberculosis
National Institute of Allergy and Infectious Diseases · R61
Contact PI · $972.1K · Iliad Biotechnologies, Llc
- 2019–2022
Novel HCN1-Selective Small Molecule Inhibitors for the Treatment of Neuropathic Pain
National Institute of Neurological Disorders and Stroke · UG3
Contact PI · $1.8M · Weill Medical Coll of Cornell Univ
- 2004–2008
Anesthetic Effects on Thalamic Synaptic Transmission
National Institute of General Medical Sciences · R01
Contact PI · $1.4M · Weill Medical Coll of Cornell Univ
Clinical trials
- 2016–2017
Prospective, Double Blind, Placebo Control, Bariatric IV Ace
Principal investigator · Completed · Phase 4
Weill Medical College of Cornell University